role of dimerization and palmitoylation on the function of htlv-1 p12 and p8

1
MEETING ABSTRACT Open Access Role of dimerization and palmitoylation on the function of HTLV-1 p12 and p8 Dustin Edwards, Risaku Fukumoto1, Nancy Van Prooyen, Heather Gold, Maria F de Castro-Amarante, Luiz Alcantara, Genoveffa Franchini * From 15th International Conference on Human Retroviruses: HTLV and Related Viruses Leuven and Gembloux, Belgium. 5-8 June 2011 HTLV-1 p12 is an endoplasmic reticulum resident pro- tein that is cleaved to generate p8, which traffics to the cell surface. p12 promotes T-cell activation by increas- ing NFAT activity while p8 induces T-cell anergy and enhances virus transmission. We have previously demonstrated that p12 and p8 coimmunoprecipitate. Though the dimerization domain of p12 and p8 is unknown, these proteins contain a single cysteine resi- due which may form intermolecular disulfide bonds. We have also determined that p8 localizes to membrane lipid rafts. Of importance, palmitoylation increases the hydrophobicity of proteins to target them to lipid rafts. As palmitoylation occurs on cysteine residues, we hypothesize that this post-translational modification reg- ulates p12 and p8 localization, dimerization, and func- tion. In this study, we have demonstrated that wildtype p12 and p8 formed hetero- and homodimers while a mutation at the cysteine residue (C39A) inhibited dimer formation and that monomeric wildtype p12 and p8, but not the C39A mutant, are pamitoylated. Immunofluores- cence analysis showed that wildtype p8 localized at the cell surface while C39A p8 did not. This result suggests that p8 homodimerization or palmitoylation regulates p8 localization. We also analyzed ex vivo DNA samples from HTLV-1-infected individuals and found DNA polymorphisms at position 39. These naturally occurring polymorphisms affected dimerization and localization of p8. Currently, we are investigating whether mutation at C39 affects NFAT activation, virus transmission, or pro- viral load. Determining the mechanism by which p12 and p8 localization, dimerization, and functions are regulated will add to our understanding of HTLV-1 pathogenesis. Published: 6 June 2011 doi:10.1186/1742-4690-8-S1-A124 Cite this article as: Edwards et al.: Role of dimerization and palmitoylation on the function of HTLV-1 p12 and p8. Retrovirology 2011 8(Suppl 1):A124. Submit your next manuscript to BioMed Central and take full advantage of: Convenient online submission Thorough peer review No space constraints or color figure charges Immediate publication on acceptance Inclusion in PubMed, CAS, Scopus and Google Scholar Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit * Correspondence: [email protected] Animal Models and Retroviral Vaccines Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 20892, USA Edwards et al. Retrovirology 2011, 8(Suppl 1):A124 http://www.retrovirology.com/content/8/S1/A124 © 2011 Edwards et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Upload: dustin-edwards

Post on 06-Jul-2016

212 views

Category:

Documents


0 download

TRANSCRIPT

MEETING ABSTRACT Open Access

Role of dimerization and palmitoylation on thefunction of HTLV-1 p12 and p8Dustin Edwards, Risaku Fukumoto1, Nancy Van Prooyen, Heather Gold, Maria F de Castro-Amarante,Luiz Alcantara, Genoveffa Franchini*

From 15th International Conference on Human Retroviruses: HTLV and Related VirusesLeuven and Gembloux, Belgium. 5-8 June 2011

HTLV-1 p12 is an endoplasmic reticulum resident pro-tein that is cleaved to generate p8, which traffics to thecell surface. p12 promotes T-cell activation by increas-ing NFAT activity while p8 induces T-cell anergy andenhances virus transmission. We have previouslydemonstrated that p12 and p8 coimmunoprecipitate.Though the dimerization domain of p12 and p8 isunknown, these proteins contain a single cysteine resi-due which may form intermolecular disulfide bonds. Wehave also determined that p8 localizes to membranelipid rafts. Of importance, palmitoylation increases thehydrophobicity of proteins to target them to lipid rafts.As palmitoylation occurs on cysteine residues, wehypothesize that this post-translational modification reg-ulates p12 and p8 localization, dimerization, and func-tion. In this study, we have demonstrated that wildtypep12 and p8 formed hetero- and homodimers while amutation at the cysteine residue (C39A) inhibited dimerformation and that monomeric wildtype p12 and p8, butnot the C39A mutant, are pamitoylated. Immunofluores-cence analysis showed that wildtype p8 localized at thecell surface while C39A p8 did not. This result suggeststhat p8 homodimerization or palmitoylation regulatesp8 localization. We also analyzed ex vivo DNA samplesfrom HTLV-1-infected individuals and found DNApolymorphisms at position 39. These naturally occurringpolymorphisms affected dimerization and localization ofp8. Currently, we are investigating whether mutation atC39 affects NFAT activation, virus transmission, or pro-viral load. Determining the mechanism by which p12and p8 localization, dimerization, and functions are

regulated will add to our understanding of HTLV-1pathogenesis.

Published: 6 June 2011

doi:10.1186/1742-4690-8-S1-A124Cite this article as: Edwards et al.: Role of dimerization andpalmitoylation on the function of HTLV-1 p12 and p8. Retrovirology 20118(Suppl 1):A124.

Submit your next manuscript to BioMed Centraland take full advantage of:

• Convenient online submission

• Thorough peer review

• No space constraints or color figure charges

• Immediate publication on acceptance

• Inclusion in PubMed, CAS, Scopus and Google Scholar

• Research which is freely available for redistribution

Submit your manuscript at www.biomedcentral.com/submit

* Correspondence: [email protected] Models and Retroviral Vaccines Section, National Cancer Institute,National Institutes of Health, Bethesda, Maryland, 20892, USA

Edwards et al. Retrovirology 2011, 8(Suppl 1):A124http://www.retrovirology.com/content/8/S1/A124

© 2011 Edwards et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative CommonsAttribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction inany medium, provided the original work is properly cited.